ClinicalTrials.Veeva

Menu
M

Morehouse School of Medicine | Clinical Research Centre

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Aspirin
Guselkumab
Montelukast
Metformin
Fluticasone
Aldosterone
Ziltivekimab
valsartan
Ustekinumab
Ivermectin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 56 total trials

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling
Heart Failure
Drug: Placebo
Drug: Ziltivekimab

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis...

Active, not recruiting
Ulcerative Colitis
Drug: Guselkumab
Drug: Placebo

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of gus...

Active, not recruiting
Crohn's Disease
Drug: Ustekinumab
Drug: Guselkumab Dose 3

The purpose of this randomized, double-blind, placebo-controlled study is to assess the efficacy of BIA 28-6156 over placebo in delaying clinical mea...

Active, not recruiting
Parkinson's Disease
Drug: Placebo
Drug: BIA 28-6156 60 mg

The purpose of this study is to study the effectiveness of implementation of a systematic LDL-C management pathway including treatment with inclisira...

Active, not recruiting
Acute Coronary Syndrome
Drug: Inclisiran

The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo

This is a prospective, multi-center interventional study of the GRAIL multi-cancer early detection (MCED) test with return of test results for partic...

Active, not recruiting
Early Detection of Cancer
Cancer
Device: Multi-Cancer Early Detection Test

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic in...

Active, not recruiting
Solid Tumor
Malignant Neoplasm
Drug: nab-sirolimus

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Other: Placebo
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Open Label Crossover Vaccination period)

This protocol describes a randomized, open-label study to evaluate the safety and tolerability of single-dose intravenous (IV) oritavancin diphosphat...

Enrolling
Acute Bacterial Skin and Skin Structure Infection
Drug: Oritavancin

Trial sponsors

M
Duke University logo
S
Janssen (J&J Innovative Medicine) logo
Amgen logo
Boehringer Ingelheim logo
Emory University logo
Hennepin Healthcare logo
Mass General Brigham logo
Novartis logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems